AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 100 filers reported holding AVIDITY BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $704,578 | -42.7% | 110,437 | -0.4% | 0.00% | 0.0% |
| Q2 2023 | $1,230,124 | +82458.7% | 110,922 | +14.2% | 0.00% | -50.0% |
| Q1 2023 | $1,490 | -16.5% | 97,097 | +20.7% | 0.00% | 0.0% |
| Q4 2022 | $1,785 | -99.9% | 80,452 | +4.1% | 0.00% | 0.0% |
| Q3 2022 | $1,262,000 | +25.2% | 77,255 | +11.4% | 0.00% | +100.0% |
| Q2 2022 | $1,008,000 | +18.3% | 69,379 | +50.4% | 0.00% | 0.0% |
| Q1 2022 | $852,000 | -18.9% | 46,130 | +4.4% | 0.00% | 0.0% |
| Q4 2021 | $1,051,000 | +0.1% | 44,198 | +3.7% | 0.00% | 0.0% |
| Q3 2021 | $1,050,000 | +13.3% | 42,624 | +13.6% | 0.00% | 0.0% |
| Q2 2021 | $927,000 | +39.2% | 37,511 | +22.9% | 0.00% | 0.0% |
| Q1 2021 | $666,000 | +35.1% | 30,526 | +58.1% | 0.00% | 0.0% |
| Q4 2020 | $493,000 | 0.0% | 19,312 | +10.3% | 0.00% | 0.0% |
| Q3 2020 | $493,000 | – | 17,516 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,571,160 | $40,096,000 | 20.10% |
| Aaron Wealth Advisors LLC | 524,239 | $13,378,000 | 4.90% |
| Octagon Capital Advisors LP | 430,041 | $10,975,000 | 3.80% |
| EcoR1 Capital, LLC | 2,103,950 | $53,693,000 | 2.89% |
| RTW INVESTMENTS, LP | 3,995,000 | $101,952,000 | 1.71% |
| ACUTA CAPITAL PARTNERS, LLC | 246,200 | $6,283,000 | 1.71% |
| Cormorant Asset Management, LP | 2,464,547 | $62,895,000 | 1.50% |
| Logos Global Management LP | 671,454 | $17,136,000 | 1.47% |
| Boxer Capital, LLC | 1,121,327 | $28,616,000 | 0.92% |
| HighVista Strategies LLC | 26,665 | $680,000 | 0.43% |